Combined Angiography Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Essential Tremors (ET) also known as benign tremor, familial tremor, and idiopathic tremor. Essential tremors are most common in people who are middle-aged and older, but anyone can suffer from this disorder

Disposable Medical Sensors: Growing demand for sensors in clinics for treatment or diagnosis purpose is driving the global market growth

Emergency Veterinary Services: Rising prevalence of zoonotic diseases would contribute in driving the growth of this market

Medical Device Technologies Market is driven by reduced time taken for recovery, a dip in overall healthcare costs; Market for Medical Device Technologies is dominated by North America, Europe

Vasomotor Symptoms of Menopause Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Cancer Cachexia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

The global single-cell analysis market is expected to register a high double-digit compounded annual growth rate (CAGR) through the review period of the report

North America accounted largest share of the global carcinoembryonic antigen market. Market for Carcinoembryonic Antigen Market is driven by increasing incidence of cancer

Wet Macular Degeneration Market: Technological advancements in suitable reimbursement circumstances is driving the growth of the market

Salmonella Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Neuroblastoma Treatment Market report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years

The eubiotic market is not only growing in the Europe and U.S but also in the developing countries such as China, India, and Brazil. Rise in the consumption of meat and dairy products are amplifying the Eubiotics Market.

The demand for empty capsules is projected to rise substantially in the years ahead thanks largely to the overall growth and expansion of the global pharmaceuticals industry

Global Biomarkers Market has witnessed improved demand in recent years due to the rapidly growing population worldwide and robust growth of the IT industry

The healthcare mobility solutions market was valued at US$20.13 bn in 2014, and is expected to reach US$148.66 bn by 2023, expanding at a CAGR of 25.50% from 2015 to 2023

Breast Cancer Therapeutics Market is expected to rise to US$16.21 bn by 2023 from US$7.17 bn in 2014, enabling the market to exhibit a CAGR of 8.4% between 2015 and 2023.

Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Nanotechnology Drug Delivery Market was valued at US$ 41,062.5 Mn in 2014 and is projected to reach US$ 118,527.2 Mn by 2023, expanding at a CAGR of 12.5% from 2015 to 2023

Exocrine Pancreatic Insufficiency Market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023.

Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Thyroid Gland Disorders is expected to progress at CAGR of 3.1% from 2015 to 2023 in terms of revenue. By the end of 2016, the revenue generated is expected to reach almost US$1.99 bn. It is expected to reach US$2.41 bn by the end of 2023

Membrane Technology Market is expected to be USD 7,029.9 million in 2014. It is likely to grow at a CAGR of 9.1% during 2014 to 2019 to reach USD 10,886 million in 2019

Global poultry pharmaceuticals market stood at US$3.7 bn in 2015 and is estimated to reach US$7.8 bn by 2024 at a strong CAGR of 8.5% therein.

Pulmonary Arterial Hypertension (PAH) Market (Prostacyclin and Prostacyclin Analogs, ERAs, PDE-5 Inhibitors, sGC Stimulators and Selexipag) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Global insulin market was valued at USD 19.99 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019 to reach USD 32.24 billion in 2019

Expanding product lines in nutrition markets, a steady infant birth rate, an aging population and several other factors are driving sales for clinical nutrition products in most of the regions worldwide

Population Health Management Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The global osteoporosis drugs market is expected to reach US$8.9 bn by the end of 2020. It was valued at US$8.4 bn in 2013 and is progressing at a CAGR of 1.2% within a forecast period from 2014 to 2020

The global animal healthcare market is expected to grow at a CAGR of 7.1% from 2014 to 2019, to reach an estimated value of USD 41,929.1 million in 2019

Sterilizers and surgical, dental care and equipment disinfectors market in India was valued at INR 806.0 Crore in 2013 and is estimated to reach a market worth of INR 1,390.2 Crore in 2020

The global GPCRs market is anticipated to increase in value from US$1.6 bn in 2013 to US$3.5 bn by 2022 at a strong 8.80% CAGR therein.

Global glioblastoma multiforme treatment market was valued at USD 0.34 billion in 2013 and is estimated to reach USD 0.91 billion by 2022 at a CAGR of 11.4% from 2014 to 2022

Global antibacterial drugs market was valued at USD 43.9 billion in 2014 and is estimated to reach USD 38.8 billion by 2023 at a CAGR of (1.3%) from 2015 to 2023

With over 70% of global population of women suffering from menopause symptoms while turning older, the biggest challenge in the global market for menopausal disorders is likely to be the adverse effects of medications.

Gastritis is characterized by a set of conditions that cause inflammation or irritation of the lining of the stomach, for a short or long time. If left untreated, gastritis caused by Helicobacter pylori can lead to ulcers and stomach cancer

Medical Education Market Expanding at a 4.3% CAGR by 2024, the global medical education market is poised to rise from a value of US$25.9 bn in 2015 to US$38.4 bn by 2024

Global Kaposi sarcoma market is projected to rise from US$118.5 mn in 2015 to reach US$143.2 mn in 2024 at a modest CAGR of 2.2% from 2016 to 2024.

Opportunities in the global pharmaceutical excipients market are primarily centered on the growing scientific understanding of functionality excipients

North America was observed to be the leading postoperative pain market because the annual procedures performed in year 2010 are 51.4 million

Global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024.

The global biologics market is anticipated to exhibit a CAGR of about 10.9% over the period between 2016 and 2024. If the number holds true, the market is expected to rise to a valuation of US$479, 752 mn by 2024.

Nonalcoholic steatohepatitis (NASH) therapeutics market is expected to expand at a CAGR of 10.7% from 2015 to 2025 to reach US$20.27 billion by 2025

Global Veterinary Therapeutics Market will expand at a healthy CAGR of 6.7% to reach US$50.2 bn by 2024; Latin America Presents Most Promising Growth Opportunities for Veterinary Therapeutics

Global PCR market is valued at USD 6,065 million in 2013 and is expected to reach USD 9,621.0 million with the CAGR of 6.6% during the forecast period of 2014 to 2020

Global Veterinary Therapeutics Market will expand at a healthy CAGR of 6.7% to reach US$50.2 bn by 2024; Latin America Presents Most Promising Growth Opportunities for Veterinary Therapeutics

Bacterial conjunctivitis drugs market in the U.S. was valued at US$473.3 mn in 2013 and is estimated to reach a market worth of US$439.8 mn in 2024, at a CAGR of 2.7% from 2012 to 2018 and (-3.73%) from 2018 to 2024

North America held the dominant share of 40.7% in the global plasma protein therapeutics market in 2015, Europe held the second largest share in the global plasma protein therapeutics market

Testosterone replacement therapy revenues will reach US$1.3 bn globally in 2024, down noticeably from US$2.0 bn in 2015. This translates to a (-4.2) % CAGR for the market from 2016 to 2024

Viral conjunctivitis pipeline drugs market is projected to reach US$ 0.5 Bn in 2023 at a CAGR of 69.6% from 2020 to 2023.